In contrast, the percentages of multiple cell subsets, such as CD3+ T cells, CD38+ CD45+ lymphocytes, and HLA-DR+ CD3+ T cells, in the PB of NSCLC patients were higher in the pneumonectomy group than in the lobectomy or sub-lobectomy groups (Figures 5H–J). This evidence concerns the gene PTPRC and non-small cell lung carcinoma.